Insider Trading Alert - ZEUS, AMED And LFUS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 6, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $199.44 to $8,899,995.42.

Highlighted Stocks Traded by Insiders:

Olympic Steel (ZEUS) - FREE Research Report

Siegal Michael D, who is Chairman of the Board and CEO at Olympic Steel, bought 500 shares at $14.98 on May 6, 2015. Following this transaction, the Chairman of the Board and CEO owned 1.2 million shares meaning that the stake was boosted by 0.04% with the 500-share transaction.

Anton Arthur F, who is Director at Olympic Steel, bought 6,315 shares at $15.68 on May 6, 2015. Following this transaction, the Director owned 21,778 shares meaning that the stake was boosted by 40.84% with the 6,315-share transaction.

The shares most recently traded at $17.11, up $1.43, or 8.36% since the insider transaction. Historical insider transactions for Olympic Steel go as follows:

  • 4-Week # shares bought: 579
  • 4-Week # shares sold: 2,700
  • 12-Week # shares bought: 10,379
  • 12-Week # shares sold: 2,700
  • 24-Week # shares bought: 10,379
  • 24-Week # shares sold: 2,700

The average volume for Olympic Steel has been 68,700 shares per day over the past 30 days. Olympic Steel has a market cap of $150.6 million and is part of the basic materials sector and metals & mining industry. Shares are down 22.95% year-to-date as of the close of trading on Monday.

Olympic Steel, Inc. processes and distributes metal products in the United States, Canada, Puerto Rico, Mexico, and internationally. It operates in two segments, Flat Products, and Tubular and Pipe Products. The stock currently has a dividend yield of 0.58%. Currently, there are no analysts who rate Olympic Steel a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ZEUS - FREE

TheStreet Quant Ratings rates Olympic Steel as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Olympic Steel Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Amedisys (AMED) - FREE Research Report

Ricchiuti Peter, who is Director at Amedisys, sold 900 shares at $27.66 on May 6, 2015. Following this transaction, the Director owned 76,600 shares meaning that the stake was reduced by 1.16% with the 900-share transaction.

The shares most recently traded at $27.79, up $0.13, or 0.46% since the insider transaction. Historical insider transactions for Amedisys go as follows:

  • 4-Week # shares sold: 23,267
  • 12-Week # shares sold: 23,267
  • 24-Week # shares sold: 23,267

The average volume for Amedisys has been 212,700 shares per day over the past 30 days. Amedisys has a market cap of $939.3 million and is part of the health care sector and health services industry. Shares are down 4.94% year-to-date as of the close of trading on Wednesday.

Amedisys, Inc., together with its subsidiaries, provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from illness, injury, or surgery. Currently, there are no analysts who rate Amedisys a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMED - FREE

TheStreet Quant Ratings rates Amedisys as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full Amedisys Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Littelfuse (LFUS) - FREE Research Report

Quille John T, who is Vice President & CAO at Littelfuse, sold 758 shares at $99.30 on May 6, 2015. Following this transaction, the Vice President & CAO owned 4,758 shares meaning that the stake was reduced by 13.74% with the 758-share transaction.

The shares most recently traded at $96.15, down $3.15, or 3.28% since the insider transaction. Historical insider transactions for Littelfuse go as follows:

  • 4-Week # shares sold: 3,900
  • 12-Week # shares sold: 11,700
  • 24-Week # shares sold: 21,500

The average volume for Littelfuse has been 129,900 shares per day over the past 30 days. Littelfuse has a market cap of $2.2 billion and is part of the services sector and wholesale industry. Shares are down 0.7% year-to-date as of the close of trading on Wednesday.

Littelfuse, Inc. designs, manufactures, and sells circuit protection devices for use in the automotive, electronic, and electrical markets worldwide. It operates in three segments: Electronics, Automotive, and Electrical. The stock currently has a dividend yield of 1.04%. The company has a P/E ratio of 23.2. Currently, there are 3 analysts who rate Littelfuse a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LFUS - FREE

TheStreet Quant Ratings rates Littelfuse as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Littelfuse Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec